Hamilton Thorne Yönetim
Yönetim kriter kontrolleri 1/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Kate Torchilin
İcra Kurulu Başkanı
n/a
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | less than a year |
| CEO sahipliği | n/a |
| Yönetim ortalama görev süresi | 1.5yrs |
| Yönetim Kurulu ortalama görev süresi | 3.8yrs |
Son yönetim güncellemeleri
Recent updates
A Piece Of The Puzzle Missing From Hamilton Thorne Ltd.'s (TSE:HTL) 47% Share Price Climb
Jul 29
These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Reasonably Well
Aug 15At CA$1.40, Is Hamilton Thorne Ltd. (CVE:HTL) Worth Looking At Closely?
May 25Is Hamilton Thorne (CVE:HTL) Using Too Much Debt?
Mar 30These 4 Measures Indicate That Hamilton Thorne (CVE:HTL) Is Using Debt Safely
Oct 05Should You Think About Buying Hamilton Thorne Ltd. (CVE:HTL) Now?
Jun 10Hamilton Thorne (CVE:HTL) Will Be Hoping To Turn Its Returns On Capital Around
May 15Is Hamilton Thorne (CVE:HTL) A Risky Investment?
Apr 12Estimating The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)
Mar 15When Should You Buy Hamilton Thorne Ltd. (CVE:HTL)?
Mar 01Has Hamilton Thorne (CVE:HTL) Got What It Takes To Become A Multi-Bagger?
Feb 01Announcing: Hamilton Thorne (CVE:HTL) Stock Soared An Exciting 590% In The Last Five Years
Jan 19Are Insiders Selling Hamilton Thorne Ltd. (CVE:HTL) Stock?
Jan 06What Did Hamilton Thorne's (CVE:HTL) CEO Take Home Last Year?
Dec 24
We Think Hamilton Thorne (CVE:HTL) Can Stay On Top Of Its Debt
Dec 12Is It Time To Consider Buying Hamilton Thorne Ltd. (CVE:HTL)?
Nov 30A Look At The Fair Value Of Hamilton Thorne Ltd. (CVE:HTL)
Nov 17CEO
Kate Torchilin
less than a year
Görev süresi
Dr. Ekaterina Torchilin PhD, MBA, also known as Kate, is President, Chief Executive Officer and Director of Hamilton Thorne Ltd. from January 15, 2024. She serves as Chief Executive Officer of Biocell Cent...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman | 13.2yrs | US$1.27m | 2.13% CA$ 7.3m | |
| Chief Financial Officer | 2.2yrs | US$476.26k | 0.025% CA$ 84.3k | |
| Vice President of Corporate Development | no data | US$395.95k | 0.021% CA$ 71.1k | |
| Senior VP & GM of HT Inc. | 3.5yrs | US$391.30k | Veri yok | |
| Managing Director of Gynemed | no data | US$247.11k | Veri yok | |
| President | less than a year | Veri yok | Veri yok | |
| Senior Vice President Global Operations & Sustaining Engineering and Management Rep | no data | US$165.49k | Veri yok | |
| Director of HR | no data | Veri yok | Veri yok | |
| President of Embryotech Laboratories Inc | no data | Veri yok | Veri yok | |
| Chief Executive Officer of Gynemed | no data | US$282.51k | Veri yok | |
| Finance Controller | no data | Veri yok | Veri yok |
1.5yrs
Ortalama Görev Süresi
Deneyimli Yönetim: HTL 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.5 yıl), bu da yeni bir ekibin varlığını gösteriyor.
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Executive Chairman | 13.2yrs | US$1.27m | 2.13% CA$ 7.3m | |
| President | less than a year | Veri yok | Veri yok | |
| Lead Independent Director | 15.1yrs | US$113.50k | 0.32% CA$ 1.1m | |
| Independent Director | 15.1yrs | US$66.00k | 13.15% CA$ 45.1m | |
| Independent Director | 17.7yrs | US$103.50k | 0.17% CA$ 577.9k | |
| Independent Director | 2.8yrs | US$113.50k | 0.060% CA$ 205.8k | |
| Independent Director | 7.8yrs | US$66.00k | 0.095% CA$ 326.2k | |
| Independent Director | 3.8yrs | US$66.00k | 0.062% CA$ 211.6k | |
| Chairman Emeritus | 2.3yrs | Veri yok | Veri yok | |
| Member of Scientific Advisory Board | 3.6yrs | Veri yok | Veri yok | |
| Independent Director | 3.8yrs | US$113.50k | 0.064% CA$ 218.0k | |
| Member of Scientific Advisory Board | 3.6yrs | Veri yok | Veri yok |
3.8yrs
Ortalama Görev Süresi
71yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: HTL 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.8 yıldır).